Accueil
Mots-clés
Thésaurus mots-clés > Pathologies organiques > Pathologies digestives et métaboliques > HEPATITE
HEPATITESynonyme(s)VHC VHBVoir aussi : |
Documents disponibles dans cette catégorie (1480)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
M. JAUFFRET-ROUSTIDE ; OUDAYA L. ; M. RONDY ; KUDAWU Y. ; Y. LE STRAT ; E. COUTURIER ; J. EMMANUELLI ; J. C. DESENCLOS |En France, la population des usagers de drogues est majoritairement masculine. Parmi ceux-ci, les profils et les pratiques des femmes sont mal connus. Entre 2004 et 2007, l'enquête ANRS-Coquelicot, alliant épidémiologie et socio-anthropologie, a[...]Rapport
Résumés de interventions en français, anglais et espagnolPériodique
E. DELAROCQUE-ASTAGNEAU | 2007FRANÇAIS : L'objectif de cette étude était d'identifier les modes de transmission potentiels du virus de l'hépatite C chez les personnes n'ayant pas d'antécédents de transfusion sanguine ou d'usage de drogues par voie intraveineuse. Cette étude[...]Périodique
N. FELIX DA COSTA | 1997FRANÇAIS : Cette étude, effectuée depuis 1991, donne les résultats de l'évaluation de l'année 1996 par rapport à l'activité clinique des Centres de Soins de Toxicodépendants (CAT) liés au Service de Prévention et Traitement de la Toxicodépendan[...]Périodique
D. L. SYLVESTRE | 2002ENGLISH : Objective: This study evaluates the safety, tolerability, and efficacy of interferon/ribavirin combination therapy in methadone maintenance (MM) patients with active hepatitis C (HCV). End-of-treatment results are presented as an int[...]Article : Périodique
I. GOUNTAS ; V. SYPSA ; O. ANAGNOSTOU ; N. MARTIN ; P. VICKERMAN ; E. KAFETZOPOULOS ; A. HATZAKIS |Aims: To project the impact of scaling-up oral anti-viral therapy and harm reduction on chronic hepatitis C (CHC) prevalence and incidence among people who inject drugs (PWID) in Greece, to estimate the relationship between required treatment le[...]NouveautéArticle : Périodique
D. WERB ; E. WOOD ; T. KERR ; N. HERSHFIELD ; R. W. H. PALMER ; R. S. REMIS |Background Canadian injection drug users (IDUs) are at high risk of hepatitis C virus infection (HCV). However, little is known about the costs associated with their HCV-related medical treatment. We estimated the medical costs of treating HCV-i[...]Article : Périodique
B. FISCHER ; J. REIMER ; FIRESTONE M. ; KALOUSEK K. ; J. REHM ; HEATHCOTE J. |Illicit drug users are the primary risk group for HCV transmission, and will form the largest HCV treatment population for years to come. Sylvestre et al.'s study suggests that cannabis use may benefit treatment retention and outcomes in illicit[...]Article : Périodique
It is currently estimated that between 2.7 million and 4.0 million persons in the United States have chronic hepatitis C virus (HCV) infection. Many of these persons have potentially progressive disease. Studies suggest that mortality and health[...]Périodique
O. DALGARD ; K. BJORO ; HELLUM K. ; MYRVANG B. ; SKAUG K. ; GUTIGARD B. ; H. BELL ; CONSTRUCT GROUP | 2002ENGLISH : Aim of the Study: To assess the long-term hepatitis C (HCV) treatment outcome in former injecting drug users (IDUs). Materials and Methods:A long-term follow-up of 27 former IDUs who had been successfully treated for chronic hepatiti[...]Périodique
M. SCHAEFER ; A. HEINZ ; M. BACKMUND | 2004ENGLISH : Aims : Approximately 170 million people world-wide are chronically infected with the hepatitis C virus (HCV). While the seroprevalence in the general population ranges between 0.2 and 2% 50-90% of injection drug users are chronically[...]Périodique
MANNS M. P. ; H. WEDEMEYER | 2004ENGLISH : In the modern era of highly active antiretroviral therapy (HAART), hepatitis C virus (HCV) has emerged as a major cause of morbidity and death in human immunodeficiency virus (HIV) infection. An estimated 15% to 30% of HIV-infected i[...]Article : Périodique
E. ASPINALL ; S. CORSON ; J. S. DOYLE ; J. GREBELY ; S. J. HUTCHINSON ; G. J. DORE ; D. J. GOLDBERG ; M. E. HELLARD |BACKGROUND: Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepatitis C (HCV) treatment, some services remain reluctant to treat PWID. The aim of this review was to investigate sustained virologic re[...]Article : Périodique
HIV-infected drug users have increased age-matched morbidity and mortality compared with HIV-infected people who do not use drugs. Substance-use disorders negatively affect the health of HIV-infected drug users, who also have frequent medical an[...]Périodique
D. GOLDBERG ; S. BURNS ; A. TAYLOR ; S. CAMERON ; HARGREAVES D. ; S. HUTCHINSON | 2001ENGLISH : In 1998, we reported that anti-HCV prevalence among injectors from Glasgow had declined between 1990 and 1995. We set out to ascertain if the anti-HCV prevalence among injectors from Edinburgh had declined similarly during this perio[...]